Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

7.969 +1.239 (+18.41%)
Streaming Delayed Price Updated: 10:00 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
62 63 Next >
Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets. 
Via Benzinga
Twitter Rebuffs Elon Musk Layoff Plans Report, Toyota Cuts 2023's Production Target, Vaccine Makers Expect 3x Price Increase In COVID-19 Shot: Top Stories Friday, Oct. 21
Bloomberg 
Via Benzinga
Is It Too Late to Buy Novavax Stock?
The company has been struggling lately. 
Via The Motley Fool
FDA Gives Emergency Nod To Novavax's Adjuvanted COVID-19 Booster Dose
Via Benzinga
Why Novavax Stock Is Skyrocketing This Week
The vaccine maker had a flurry of good news. 
Via The Motley Fool
Jim Cramer Says This Stock 'Down Here At This Level Is A Terrific Buy'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is against Novavax (NASDAQ: NVAX). 
Via Benzinga
Vaccine Makers Mull Price Increase For COVID-19 Boosters Amid Falling Demand
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector... 
Via Benzinga
Why Moderna Stock Dropped Today
Competition is intensifying. 
Via The Motley Fool
Why Novavax Stock Couldn't Win on Wednesday
FDA authorization isn't necessarily a slam dunk for a company. 
Via The Motley Fool
Why Novavax's Uphill Battle Continues Despite Winning U.S. Booster Authorization
Novavax's booster could be used by half of U.S. adults. But, will it? 
Via Investor's Business Daily
What's Going On With Novavax Shares Spiking Higher Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 1.60% to $18.92 Wednesday morning. The FDA granted Emergency Use Authorization for the company's COVID-19 vaccine as a booster for adults after... 
Via Benzinga
More Likely to Double First: Teladoc or Novavax?
Both stocks soared during the early days of the pandemic. 
Via The Motley Fool
Why BioNTech SE And Novavax Shares Are Diving
BioNTech SE - ADR (NASDAQ: BNTX) and Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 4.07% to $133.28 and 7.68% to $18.76, respectively, ahead of the close of Tuesday's session. Vaccine stock 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Got $300? 3 Genius Stocks to Buy on the Dip
You don't need a boatload of cash to begin building wealth on Wall Street. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022?
These four tech stocks are down nearly 90%. 
Via The Motley Fool
Why Novavax Stock Had an Ugly Friday
Investors ding the biotech's shares one day after it reported quite good news about an experimental vaccine. 
Via The Motley Fool
Microsoft To $325? Plus This Analyst Sees BlackRock Dropping By 15%
Morgan Stanley lowered the price target on Microsoft Corporation (NASDAQ: MSFT) from $354 to $325. Microsoft shares fell 0.3% to $233.50 in pre-market trading. 
Via Benzinga
What's Going On With Novavax Shares?
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 6.80% to $20.26 going into the close of Wednesday's trading session after the company reported the results from its Phase 3 PREVENT-19 trial... 
Via Benzinga
KnowBe4 (KNBE) Stock Jumps 12% on Take-Private Deal
KnowBe4 (KNBE) stock is getting a boost on Wednesday as investors react to a deal that will take the cybersecurity company private. 
Via InvestorPlace
Novavax Prototype COVID-19 Vaccine Data Shows Benefit Against Variants
Novavax Inc (NASDAQ: NVAX) presented data from the Phase 3 PREVENT-19 trial and Study 307 (Lot Consistency) at the World Vaccine Congress Europe 2022.  
Via Benzinga
Why Is Novavax (NVAX) Stock in the Spotlight Today?
Novavax (NVAX) stock is on the move Wednesday following positive data from its Phase 3 PREVENT-19 vaccine trial and Study 307. 
Via InvestorPlace
Is Pfizer Stock Still Worth Buying After the Pandemic?
Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations. 
Via MarketBeat
Exposures COVID-19
5 Investors Betting Big on Novavax (NVAX) Stock
NVAX stock is in focus as the company receives a recommendation from the Swiss health agency concerning its Nuvaxovid drug. 
Via InvestorPlace
Novavax (NVAX) Stock Pops 8% With Vaccine Talks Underway
Today, investors in Novavax and NVAX stock are cheering the start of a major conference on vaccine tech, which Novavax is a part of. 
Via InvestorPlace
What's Going On With Novavax Shares?
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 11.4% to $19.80 Tuesday afternoon ahead of the company's presentation of data at the World Vaccine Congress Europe 2022 this week. What Else? 
Via Benzinga
Jim Cramer Says Stay Away From This Cybersecurity Company; He's Been 'Against Them The Whole Way Down'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said BlackBerry Limited (NYSE: BB) is losing money and he's been "against them the whole way down." 
Via Benzinga
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued... 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
62 63 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.